This CTD dossier owner and manufacturer company is a WHO-GMP certified manufacturer and exporter focused on producing a wide range of formulations including beta-lactam products, effervescents, injections, eye/ear/nasal drops, ointments, veterinary medications, hormones, and food supplements. They target key regions in the Middle East, Africa, and Asia with an emphasis on brand building in export markets. The company holds multiple awards for its product quality and export excellence. Their commitment to quality is reflected in their ISO 9001:2008 certification and they prioritize ethical decision-making and transparency. The broad range of products suggests a focus on both acute and chronic conditions.

This CTD dossier owner and manufacturer is a technology-driven enterprise with a focus on product quality and timely delivery. Its ultra-modern, WHO and GMP-certified manufacturing facility is located in a pollution-free industrial estate near major SEZ hubs in Asia. The company exports its products to Southeast Asia, Africa, the CIS region, Latin America & Central America, and the GCC. They supply prescription medications and likely over-the-counter drugs, as indicated by their global distribution network. They emphasize a "human approach" to business with trade partners and prioritize ethical production practices.

This pharmaceutical company, established in 2005, offers a range of products including prescription medications, over-the-counter drugs, medical devices, and supplements. They focus on key therapy areas such as hepatology and pain management, delivering these through various dosage forms like syrups, tablets, injections, capsules, and ointments. Operating across North America, the EU, and other regions, this company is WHO-GMP and ISO 9001-2015 certified. They have a strong track record of success, evidenced by their partnerships with leading pharmaceutical companies and awards recognizing their commitment to quality.